醫用幾丁聚醣市場：按產地、應用和地區分類

Medical Grade Chitosan Market, By Origin, By Application, By Geography

出版日期: 2026年07月30日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，醫用幾丁聚醣市場規模將達到 4.305 億美元，到 2033 年將達到 9.219 億美元。預計 2026 年至 2033 年的複合年成長率將達到 11.5%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	4.305億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.50%	2033年市場規模預測：	9.219億美元

醫用級幾丁聚醣是一種生物聚合物，由從甲殼類動物外殼和真菌中提取的幾丁質經過高度純化而得。其安全性、凝膠性和黏膜黏附性使其成為創傷護理、藥物傳遞、組織工程、外科產品和眼科應用的理想材料。它符合嚴格的藥典和監管標準，適用於臨床和體內應用。

全球醫用幾丁聚醣市場的發展主要受以下因素驅動：對永續生物材料日益成長的需求、再生醫學的進步以及藥物研發的拓展。除了生物基材料在醫療領域的應用日益廣泛外，先進藥物遞送和組織再生技術的持續創新預計也將推動市場在預測期內持續成長。

市場動態

全球醫用幾丁聚醣市場成長的主要驅動力是其在慢性傷口護理、外科手術和再生醫學等領域的應用日益廣泛，這些應用推動了對先進傷口敷料、止血劑和組織工程材料的需求。標靶藥物遞送系統的日益普及以及對生物聚合物基醫療產品法規結構的支持，進一步加速了市場成長。

然而，該市場面臨諸多限制因素，包括高昂的製造成本、複雜的提純製程、原料的不穩定性以及嚴格的監管要求。儘管如此，真菌來源的幾丁聚醣作為甲殼類動物來源殼聚醣的替代品而開發的進展、幾丁聚醣奈米顆粒在藥物遞送和腫瘤治療領域日益廣泛的應用，以及新興經濟體醫療基礎設施的完善和先進創傷護理的普及，都將為醫用幾丁聚醣市場帶來新的成長機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球醫用幾丁聚醣市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球醫用幾丁聚醣市場報告」旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球醫用幾丁聚醣市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第7章競爭情勢

公司簡介
- Primex ehf
- KitoZyme SA
- BIO21 Co., Ltd.
- KIMICA Corporation
- NovaMatrix
- Yaizu Suisankagaku Industry Co., Ltd.
- Golden-Shell Pharmaceutical Co., Ltd.
- Heppe Medical Chitosan GmbH
- Ningbo Zhenhai Haixin Biological Products Co., Ltd.
- trA«Chitosan

第8章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第9章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9870

Medical Grade Chitosan Market is estimated to be valued at USD 430.5 Mn in 2026 and is expected to reach USD 921.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 430.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.50%	2033 Value Projection:	USD 921.9 Mn

Medical grade chitosan is a biopolymer obtained from highly refined chitin isolate from crustacean shells or fungi. Due to its Safety, Gelation, and Mucoadhesive capacity in nature, it is a material of choice for wound care, drug delivery, tissue engineering, surgical products, and ophthalmic applications. Its compliance with stringent pharmacopeial and regulatory standards makes it suitable for clinical and in vivo use.

The global medical grade chitosan market is driven by increasing demand for sustainable biomaterials, advancements in regenerative medicine, and expanding pharmaceutical research. The growing use of bio-based materials in healthcare, along with ongoing innovation in advanced drug delivery and tissue regeneration technologies, is expected to drive continued market growth during the forecast period.

Market Dynamics

The global medical grade chitosan market is driven by rising prevalence of chronic wounds, surgical procedures, and regenerative medicine applications, which are increasing demand for advanced wound dressings, hemostatic agents, and tissue engineering materials. Growing adoption of targeted drug delivery systems and supportive regulatory frameworks for biopolymer-based medical products are further accelerating market growth.

However, a number of constraints are present in the market, such as high production costs, complex purification processes, raw material variability, and stringent regulatory requirements. Nevertheless, development of fungal-derived chitosan as a shellfish-free alternative, increasing use of chitosan nanoparticles in drug delivery and oncology, and expanding healthcare infrastructure and advanced wound care adoption across emerging economies will offer new opportunities for growth in medical grade chitosan market.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global medical grade chitosan market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Primex ehf, KitoZyme S.A., BIO21 Co., Ltd., KIMICA Corporation, NovaMatrix, Yaizu Suisankagaku Industry Co., Ltd., Golden-Shell Pharmaceutical Co., Ltd., Heppe Medical Chitosan GmbH, Ningbo Zhenhai Haixin Biological Products Co., Ltd., and trA« Chitosan
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global medical grade chitosan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical grade chitosan market

Market Segmentation

Origin Insights (Revenue, USD Mn, 2021 - 2033)
Animal Based
Plant Based
Application Insights (Revenue, USD Mn, 2021 - 2033)
Drug Delivery
Drug Formulation
Gene Delivery
Wound Management
Tissue Engineering
Disease Diagnosis and Medical Implants
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Primex ehf
KitoZyme S.A.
BIO21 Co., Ltd.
KIMICA Corporation
NovaMatrix
Yaizu Suisankagaku Industry Co., Ltd.
Golden-Shell Pharmaceutical Co., Ltd.
Heppe Medical Chitosan GmbH
Ningbo Zhenhai Haixin Biological Products Co., Ltd.
trA« Chitosan

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Medical Grade Chitosan Market, By Origin
- Global Medical Grade Chitosan Market, By Application
- Global Medical Grade Chitosan Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Medical Grade Chitosan Market, By Origin, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Animal Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Plant Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Medical Grade Chitosan Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Drug Formulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Wound Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Disease Diagnosis and Medical Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Medical Grade Chitosan Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Company Profile
- Primex ehf
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- KitoZyme S.A.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BIO21 Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- KIMICA Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- NovaMatrix
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Yaizu Suisankagaku Industry Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Golden-Shell Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Heppe Medical Chitosan GmbH
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Ningbo Zhenhai Haixin Biological Products Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- trA« Chitosan
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies